DPL responds to HHS Blueprint (May 16, 2018)

Drug Pricing Lab
July 17, 2018

The Drug Pricing Lab responds to the Trump Administration’s Request for Information on lowering drug prices with a summary of our findings related to value-based arrangements, competitive acquisition, fixing global freeloading, reducing the impact of rebates, and copay discount cards.

Download the report here.